Get access to over 20 years of real-world data (RWD) in long-term and post-acute care (LTPAC) to create a future with improved senior patient outcomes. PointClickCare provides near real-time availability of de-identified patient therapy data, treatment information, detailed outcomes of results from treatments, and more.
Leverage the largest senior care database with over 1.4 million active patients from over 22,000 skilled nursing facilities and 4,000 assisted living facilities using our software. Well over 50% of our SNF customers have opted-in to share their data – stripped of all personal identification information.
Gain access to right types of data for your specific study. De-identified patient data relating to outcomes and biomarkers, diagnosis and co-morbidities, treatment and therapy, encounters, claims, MDS assessments, and more is available.
PointClickCare is helping the U.S. Centers for Disease Control and Prevention (CDC) conduct a comprehensive analysis on disease patterns, progression, and health outcomes and to evaluate clinical guidelines uptake, treatments, and interventions by providing a key data source.
Help advance research for effective treatment options in the long-term and post-acute care demographic with access to the largest senior care patient database in existence. Gain insights into the determinants and patterns of health-related states and events in senior health care and help identify correlations between specific treatment options and their outcomes.
Why customers choose our clinical/research data:
Speak with an expert to learn how our de-identified clinical/research data can be utilized for epidemiological research, prospective studies, or health economics and outcomes research (HEOR).
Utilize real-world data of the long-term and post-acute care demographic to help discover potential lifesaving or life altering therapies for the senior population. Encourage more data enriched research with this wealth of data for your research and development teams to be able to develop a deeper understanding of the LTPAC demographic.
Why customers choose our commercial data:
Schedule a consultation to learn how our de-identified commercial data sets can enhance real-world evidence (RWE) studies, pragmatic clinical trials, patient journey studies, or a drug utilization review (DUR).
